BevCanna Enterprises

ENTOURAGE HEALTH OTCMKTSWDDMF STOCK QUOTE

https://www.weedmd.com/

LATEST NEWS FROM ENTOURAGE HEALTH

Entourage Health Launches Fire & Flower-branded CBD Softgel Product Line

Entourage Health Announces New Ticker Symbol on U.S.-Based OTCQX Market as ‘ETRGF’ Effective September 1, 2021

Entourage Health Partners with Boston Beer Subsidiary to Launch and Sell Portfolio of Innovative Cannabis-Infused Beverages in Canada

Entourage Health Expands its Saturday Cannabis Brand into Quebec

Entourage Health Reports Q2 Financial Results with $13.8 Million Record Revenue Representing 92% YOY Increase and Third Consecutive Quarter of Growth

Entourage Health Announces Preliminary Record Q2 Revenues of $13.6 Million and Confirms Financial Results Call to be Held on August 10, 2021 at 10 a.m. ET

Entourage Health Announces Debut of New Ticker “ENTG” on TSX Venture

WeedMD Inc. and CannTx Life Sciences Sign Definitive Acquisition Agreement and Confirm Corporate Name as Entourage Health Corp.

WeedMD Inc. Announces Intent to Change Corporate Name to Entourage Health Corp.

WeedMD Reports First Quarter 2021 Financial Results with 102% Record Increase in Sequential Net Revenue Growth

WeedMD Expands its Color Cannabis Brand into the Province of New Brunswick

WeedMD Sells Fully Licensed Bowmanville Operating Assets

WeedMD Inc. Provides Bi-Weekly Status Report Regarding Management Cease Trade Order and Update Regarding Interim Financial Statements

WeedMD and Privately Owned CannTx Life Sciences Sign Letter of Intent to Create a Cannabis Cultivation and Consumer-Centric Product Portfolio

WeedMD Reports Fiscal Year 2020 Financial Results and First Quarter 2021 Preliminary Gross Revenue of $12 Million

WeedMD to Host Fiscal Year End 2020 Conference Call on May 31st

WeedMD Launches New Product Collaboration with CannTx Life Sciences for Release of Limited Edition Cultivars to Starseed Medicinal

WeedMD Inc. Provides Bi-Weekly Status Report Regarding Management Cease Trade Order and Update Regarding Interim Financial Statements

WeedMD Management to Present at Canaccord Genuity’s Annual Global Cannabis Virtual Conference on May 11th

WeedMD Inc. Granted Management Cease Trade Order

WeedMD Announces Delayed Filing of its 2020 Annual Financial Disclosure

WeedMD Announces Participation in Upcoming Investor Events

WeedMD Appoints Dynamic Leader Beth Carreon as New Chief Financial Officer

WeedMD to Host Fiscal Year-End 2020 Conference Call on April 30, 2021

WeedMD Added to Horizons Marijuana Life Sciences Index ETF

WeedMD Announces Supplemental Listing of Warrants

WeedMD’s Color Cannabis Expands Product Portfolio with Debut of Live Resin in Pedro’s Sweet Sativa Cultivar

WeedMD Announces Closing of $17.25 Million Bought Deal Offering

WeedMD Inc. Announces Amendment of Bought Deal Equity Financing

WeedMD Files Amended Third Quarter 2020 Interim Financial Statements

WeedMD’s Starseed Medicinal Announces the Release of Strain-Specific Products for PAX® ERA® Vaporizer

WeedMD Announces Mary’s Medicinals Topicals Product Release in Canada

WeedMD Inc. Announces Increase in Bought Deal Equity Financing to $17.5 Million

WeedMD’s Saturday Cannabis Vaporizers Debut as the Top Seller in Ontario and Color Cannabis Brand Launches 15 gram Dried Flower Products

WeedMD Confirms its Color Cannabis Products Now in Stock in Quebec

WeedMD’s Starseed Medicinal Signs Sixth LiUNA Local to Medical Cannabis Program and Expands Coverage to Manitoba